SolasCure publishes phase IIa clinical trial report in leading wound care journal Post author: Post published:March 4, 2024 Post category:uncategorized Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds. You Might Also Like SMART software offers new solution for modeling cell-signaling networks December 19, 2024 Restricted diet triggers drop in microbial diversity without convergence July 22, 2025 California’s nursing shortage is getting worse. Front-line workers blame management. October 8, 2025